Following this settlement, Lupin is now eligible for selling the generic versions of Solodyn in 45mg, 90mg, and 135mg strengths under a license from Medicis commencing November 2011, or earlier under certain conditions.
The settlement also allows Lupin to sell the generic versions of Solodyn in 65mg and 115mg strengths
under a license from Medicis effective in February 2018.
Additionally, with this settlement Lupin is also eligible for selling generic versions of Solodyn in 55mg, 80mg and 105mg strengths as per a license from Medicis effective in February 2019.